NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
UFLEX Q3 FY26: PAT at Rs 361 Mn; Aseptic Packaging Volumes Rise to 1.8 Bn Packs
UFLEX reported Q3 FY26 revenue of Rs 36,329 million, a 3.8% YoY decline due to volume softness and pricing pressure, but achieved a PAT of Rs 361 million, up 34% sequentially. The aseptic packaging business showed steady growth with volumes rising to 1.8 billion packs in Q3, and management has set an ambitious target of 8.5 billion packs for FY27. Management indicated that debt levels have likely peaked as major expansion projects in Egypt, India, and Mexico near completion. Normalized EBITDA margins improved to 12.1%, a 200 bps expansion quarter-on-quarter, driven by operational discipline.
முக்கிய அம்சங்கள்
Q3 FY26 PAT stood at Rs 361 million with an EPS of Rs 5.01 per share.Normalized EBITDA grew 12.8% sequentially to Rs 4,395 million with margins at 12.1%.Aseptic liquid packaging volumes grew 4.4% in 9M FY26 to 5.9 billion packs.Three major projects in Egypt, India, and Mexico are nearing the commissioning stage.Management expects aseptic packaging sales to reach 8.5 billion packs in the next fiscal year.
👀 கவனிக்க வேண்டியவை
Investors should focus on the commissioning of the Egypt and Mexico projects as key drivers for EBITDA growth and debt reduction. The recovery in film pricing and growth in the high-margin aseptic segment provide a constructive outlook for the stock.
UFLEX to Acquire 28% Stake in Ampin C&I Power for Rs 6.67 Cr for Captive Hybrid Power
UFLEX Limited has entered into a Power Purchase Agreement and Share Subscription Agreement to acquire a 28% equity stake in Ampin C&I Power Twenty-Seven Private Limited. The investment, totaling Rs 6.67 crore, is aimed at sourcing hybrid (Solar + Wind) power on a long-term basis. This move follows the captive power plant policy, which requires users to hold at least a 26% stake in the generating entity. The target company is a newly incorporated entity focused on renewable energy generation in India.
முக்கிய அம்சங்கள்
Acquisition of 28% equity stake involving 66,66,000 shares at Rs 10 each.Total cash consideration for the investment is Rs 6.67 crore.Investment facilitates long-term access to hybrid (Solar and Wind) power for captive use.Target entity is a newly incorporated company (July 2025) with zero current turnover.Transaction is expected to be completed within 7 business days.
👀 கவனிக்க வேண்டியவை
This is a strategic move to lower long-term energy costs and improve ESG ratings. Investors should view this as a positive step toward operational efficiency and sustainability.
UFLEX Targets 24 Billion Aseptic Pack Capacity by FY26 Amid Global Expansion
UFLEX Limited is aggressively scaling its operations with a total global capacity of 1,351,910 MTPA across 17 manufacturing units. The company is on track to reach a nameplate capacity of 24 billion aseptic liquid packs per year by FY2026, supported by a new 12 billion pack plant in Egypt. Additional 2026 projects include an 80 million capacity WPP bag facility in Mexico and new recycling plants in Noida. The company aims to capitalize on India's projected 10.2% packaging market CAGR and a resilient 7.4% GDP growth forecast for FY26.
முக்கிய அம்சங்கள்
Total global manufacturing capacity reaches 1,351,910 MTPA across films, resins, and chemicals.Aseptic liquid packaging capacity set to double to 24 billion packs per year by FY2026.Planned commissioning of a 12 billion packs/annum aseptic plant in Egypt and 80 million WPP bag facility in Mexico in 2026.Upcoming 54,000 MTPA BOPP line expansion in Dharwad, India, to strengthen domestic presence.Focus on sustainability with new PCR PET and PCR MLP recycling plants being established in Noida.
👀 கவனிக்க வேண்டியவை
Investors should focus on the timely execution of the Egypt and Mexico expansions as these high-margin segments are critical for valuation re-rating. Monitor the recovery in BOPET film pricing which has shown recent quarter-on-quarter improvement.
UFLEX reported a mixed performance for Q3 FY26, with revenue declining 3.8% YoY to Rs 36,329 million due to lower packaging film volumes and realization pressures. However, normalized EBITDA showed a sequential recovery, growing 12.8% QoQ to Rs 4,395 million with margins expanding by 200 bps to 12.1%. The company is heavily investing in growth, with major capex projects in Egypt, Mexico, and India totaling over Rs 4,342 million in Q3 alone. While domestic and US markets faced headwinds from inventory destocking and soft demand, management expects a recovery in Q4 FY26 driven by easing imports and improved utilization.
முக்கிய அம்சங்கள்
Q3 FY26 Revenue stood at Rs 36,329 Mn, down 3.8% YoY and 5.9% QoQ.Normalized EBITDA reached Rs 4,395 Mn, up 12.8% QoQ but down 16.1% YoY.Sales volume for Q3 FY26 was 151,245 MT, reflecting a 3.7% YoY decline.Incurred Rs 4,342 Mn capex in Q3 for global projects including Egypt Aseptic and Mexico WPP plants.Net debt remains substantial at Rs 81,810 Mn as of December 31, 2025.
👀 கவனிக்க வேண்டியவை
Investors should closely monitor the timely commissioning of the Egypt Aseptic and Mexico WPP facilities in FY26, which are critical for future volume growth. While sequential margin improvement is positive, the high debt levels and global demand volatility warrant a cautious approach.
UFlex Q3 FY26: Normalized EBITDA Grows 12.8% QoQ to Rs 4,395 Mn; PAT at Rs 486 Mn
UFlex reported a resilient Q3 FY26 with consolidated revenue of Rs 36,329 million, down 3.8% YoY but showing sequential margin improvement. Normalized EBITDA grew 12.8% QoQ to Rs 4,395 million, with margins expanding 200 bps to 12.1% despite global trade uncertainties and import-led price pressures. For the nine-month period (9M FY26), the company returned to profitability with a PAT of Rs 1,211 million compared to a loss of Rs 262 million in the previous year. Management remains constructive on the outlook, supported by upcoming capacity expansions in Egypt and Mexico.
முக்கிய அம்சங்கள்
Normalized EBITDA increased 12.8% QoQ to Rs 4,395 million, with margins improving to 12.1%.9M FY26 PAT stood at Rs 1,211 million, a significant turnaround from a net loss of Rs 262 million in 9M FY25.Packaging segment sales volume grew 7.6% YoY to 36,280 MT, while Packaging Films volume declined 6.8% YoY.Consolidated sales volume for Q3 FY26 was 151,245 MT, down 3.7% YoY and 6.2% QoQ.India remains the largest revenue contributor at 46.1%, followed by the Americas at 18.9% and Europe at 17.4%.
👀 கவனிக்க வேண்டியவை
Investors should focus on the sequential recovery in margins and the commissioning of new capacities in Egypt and Mexico as potential growth catalysts. However, caution is advised regarding global trade barriers and domestic import pressures that continue to impact the packaging films segment.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
UFLEX Q3 FY26 Consolidated Net Profit Drops 73.6% YoY to ₹36.15 Crore
UFLEX reported a consolidated revenue of ₹3,612 crore for Q3 FY26, a decline of 3.3% compared to ₹3,734.7 crore in the same quarter last year. Net profit after minority interest fell sharply by 73.6% YoY to ₹36.15 crore, though it showed a sequential recovery from ₹26.9 crore in Q2 FY26. Profitability was impacted by rising finance costs, which reached ₹192.9 crore, and a one-time exceptional charge of ₹12.45 crore related to New Labour Code provisions. Additionally, the company is currently contesting a significant Income Tax demand of ₹412.81 crore.
முக்கிய அம்சங்கள்
Consolidated Revenue from operations stood at ₹3,612 crore, down 3.3% YoY from ₹3,734.7 crore.Net Profit after tax (attributable to owners) plummeted to ₹36.15 crore from ₹136.8 crore in Q3 FY25.Finance costs rose to ₹192.9 crore in Q3 FY26, up from ₹174.3 crore in the year-ago period.Recognized an exceptional expense of ₹1,245 lacs (₹12.45 crore) due to legislative amendments in Labour Codes.Ongoing legal risk with an Income Tax demand of ₹41,280.99 lacs (₹412.81 crore) currently under appeal.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution given the significant year-on-year contraction in margins and the large outstanding tax demand. The stock may remain under pressure until there is clarity on the tax litigation and an improvement in the core flexible packaging segment's profitability.
UFLEX CFO Rajesh Bhatia Retires Effective February 4, 2026
UFLEX Limited has announced the retirement of Mr. Rajesh Bhatia from his position as Group President (F&A) and Chief Financial Officer. The cessation of his role as a Key Managerial Personnel (KMP) is effective from the close of business hours on February 4, 2026. This change is attributed to superannuation, representing a planned leadership transition within the company's finance department. Investors should note that a successor has not yet been named in this specific regulatory filing.
முக்கிய அம்சங்கள்
Mr. Rajesh Bhatia ceased to be the CFO and KMP effective February 4, 2026The departure is due to superannuation (retirement) from his role as Group President (F&A)He also ceases to be the authorized person for determining materiality under SEBI Regulation 30(5)The disclosure was made in compliance with SEBI Listing Regulations, 2015
👀 கவனிக்க வேண்டியவை
Investors should monitor future filings for the appointment of a new CFO to ensure continuity in financial management. As this is a planned retirement, it is unlikely to impact short-term stock performance.
UFLEX Investor Presentation: Capacity at 1,351,910 MTPA
UFLEX Limited has released an investor presentation highlighting its global presence and expansion plans. The company has a global capacity of 1,351,910 MTPA and a presence across 150+ countries. UFLEX is expanding its aseptic packaging capacity to 12 Billion packs/year by FY26, with a brownfield expansion commissioned in Sanand, increasing capacity to 12 Bn/year from 7 Bn. The company is also setting up two recycling plants in Noida for PCR PET chips and PCR MLP.
முக்கிய அம்சங்கள்
Global Capacity of 1,351,910 MTPAPresence across 150+ countriesAseptic Liquid Packs Capacity of 12bn (Standard 200 ML pack basis)Recycling Capacity of 74,317 MTPAPlanned commissioning of 80 million capacity WPP bag facility in Mexico by 2026
👀 கவனிக்க வேண்டியவை
Investors should review the investor presentation to understand UFLEX's growth strategy and expansion plans. Monitor the progress of the aseptic packaging capacity expansion and the establishment of recycling plants.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
